Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Current Deferred Revenue (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Current Deferred Revenue of $142 million in Q3 2026, down 25.3% from $190 million a year earlier and down 9.0% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Current Deferred Revenue (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb reported Current Deferred Revenue of $175 million, down 21.2% from FY2024.

  • Annual Current Deferred Revenue has declined for six straight years, with a five-year compound annual growth rate of -13.7% (FY2020 to FY2025).
  • Across earlier years, Current Deferred Revenue came in at $222 million in FY2024 (-19.0%), $274 million in FY2023 (-5.2%), $289 million in FY2022 (-12.4%) and $330 million in FY2021 (-9.8%).
  • The Q3 2026 figure is the lowest quarterly Current Deferred Revenue since Q1 2019.
  • On a year-over-year basis, Current Deferred Revenue has declined for 24 consecutive quarters, with an average decline of 20.8% over the last eight quarters.
  • Across the past five years, year-over-year decline in Current Deferred Revenue ran from 3.7% in Q1 2023 to 25.3% in Q3 2026.
  • Per Business Quant, the preceding three quarters came in at $156 million (Q2 2026), $168 million (Q1 2026) and $175 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 142.00 Mn
Jun 30, 2026 156.00 Mn
Mar 31, 2026 168.00 Mn
Dec 31, 2025 175.00 Mn
Sep 30, 2025 190.00 Mn
Jun 30, 2025 203.00 Mn
Mar 31, 2025 217.00 Mn
Dec 31, 2024 222.00 Mn
Sep 30, 2024 236.00 Mn
Jun 30, 2024 248.00 Mn
Mar 31, 2024 263.00 Mn
Dec 31, 2023 274.00 Mn
Sep 30, 2023 289.00 Mn
Jun 30, 2023 300.00 Mn
Mar 31, 2023 314.00 Mn
Dec 31, 2022 289.00 Mn
Sep 30, 2022 304.00 Mn
Jun 30, 2022 321.00 Mn
Mar 31, 2022 326.00 Mn
Dec 31, 2021 330.00 Mn
API Access

Bristol Myers Squibb Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BMY&period=max&api_key=YOUR_API_KEY